07 - 10 April, 2024
The Westin Fort Lauderdale Beach Resort
Fort Lauderdale, Florida USA
Events
Sarah Bohndiek
University of Cambridge, UK
Harnessing the Power of Spectroscopy in Early Cancer Detection
Hyperspectral imaging technologies hold promise for revolutionising cancer diagnosis and treatment. By introducing innovations in translational biophotonics, I will demonstrate the power of spectroscopy to enable earlier detection of cancer and democratise access to high quality diagnostics.
About the Speaker
Sarah Bohndiek completed her PhD in Radiation Physics at University College London in 2008 and then worked in both the UK (at the University of Cambridge) and the USA (at Stanford University) as a postdoctoral fellow in molecular imaging. Sarah joined the University of Cambridge in 2013, where she is jointly appointed as a Professor of Biomedical Physics in the Department of Physics and at the Cancer Research UK Cambridge Institute. Sarah was elected Fellow of the international optics and photonics society SPIE in 2020.
Sarah’s interdisciplinary team, the VISIONLab, is pushing the boundaries of optical imaging technology to address the major unmet clinical need for earlier cancer detection. The VISIONLab creates innovative methods to visualize complex biological processes in situ using light and sound, enabling translation of their measurements into meaningful insights through early stage testing in model systems and human trials.
In addition to her research program, Sarah also takes a proactive role in teaching and mentoring the next generation of scientists. She has acted as an ambassador for public and media engagement as well as interdisciplinary research training throughout her career.
